Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Domingo-Domènech, Eva
344  Ergebnisse:
Personensuche X
?
1

Nivolumab plus brentuximab vedotin for relapsed/refractory ..:

Zinzani, Pier Luigi ; Salles, Gilles ; Moskowitz, Alison J....
Blood Advances.  8 (2024)  10 - p. 2400-2404 , 2024
Link: https://doi.org/10.1182/..
 
?
2

18F-FDG-PET/CT response after first-line treatment as a pro..:

Cordoba, Raul ; Sánchez-García, Joaquín ; Domingo-Domenech, Eva...
Expert Review of Hematology.  17 (2024)  1-3 - p. 95-100 , 2024
Link: https://doi.org/10.1080/..
 
?
3

The Etiology, Antibiotic Therapy and Outcomes of Bacteremic..:

Castelli, Valeria ; Sastre-Escolà, Enric ; Puerta-Alcalde, Pedro...
Antibiotics.  12 (2023)  12 - p. 1722 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Blood neurofilaments as biomarkers of chemotherapy-induced ..:

Velasco, Roser ; Marco, Carla ; Ferrer, Germán...
Journal of the Neurological Sciences.  455 (2023)  - p. 122081 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Unraveling the genetics of transformed splenic marginal zon..:

Grau, Marta ; López, Cristina ; Navarro, Alba...
Blood Advances.  7 (2023)  14 - p. 3695-3709 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Role of stem cell transplant in CD30+ PTCL following frontl..:

Savage, Kerry J. ; Horwitz, Steven M. ; Advani, Ranjana...
Blood Advances.  6 (2022)  19 - p. 5550-5555 , 2022
Link: https://doi.org/10.1182/..
 
?
7

Anti-CD30 antibody–drug conjugate therapy in lymphoma: curr..:

Prince, H. Miles ; Hutchings, Martin ; Domingo-Domenech, Eva..
Annals of Hematology.  102 (2022)  1 - p. 13-29 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Impact of pre- and/or post-autologous stem cell transplanta..:

Martínez, Carmen ; de Haro, Manuel Espeso ; Romero, Samuel...
Annals of Hematology.  102 (2022)  2 - p. 429-437 , 2022
Link: https://doi.org/10.1007/..
 
?
9

T021: Radiation-Free Therapy as the INitial treatment of Go..:

Gallamini, Andrea ; Picardi, Marco ; Filonenko, Kateryna...
HemaSphere.  6 (2022)  - p. 10-11 , 2022
Link: https://doi.org/10.1097/..
 
?
10

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP..:

Sureda-Balari, Anna ; Terol, M. José ; Domingo-Domènech, Eva...
HemaSphere.  6 (2022)  - p. 45-45 , 2022
Link: https://doi.org/10.1097/..
 
?
11

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in ..:

Oliveira, Ana C. ; Roncero, Josep Maria ; Ferrá, Christelle...
International Journal of Hematology.  117 (2022)  3 - p. 388-397 , 2022
Link: https://doi.org/10.1007/..
 
?
12

TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomize..:

Iyer, Swaminathan ; Trümper, Lorenz ; O'Connor, Owen A....
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S411 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results..:

Iyer, Swaminathan ; Trümper, Lorenz ; O'Connor, Owen A....
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S203 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Brentuximab-Induced Peripheral Neurotoxicity: A Multidiscip..:

Velasco, Roser ; Domingo-Domenech, Eva ; Sureda, Anna
Cancers.  13 (2021)  23 - p. 6125 , 2021
Link: https://doi.org/10.3390/..
 
?
15

Extramedullary multiple myeloma patient derived orthotopic ..:

Farre, Lourdes ; Sanz, Gabriela ; Ruiz-Xivillé, Neus...
Disease Models & Mechanisms.  , 2021
Link: https://doi.org/10.1242/..
 
1-15